Which trial do we need? Rational therapeutic management of periprosthetic joint infection

The Impact of Surgeon Variability on Patient-Reported Outcome Measures, Length of Stay, Discharge Disposition, and 90-Day Readmission in TKA

(2022) SaTia T. Sinclair et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

The limits of shared decision making

(2022) Glyn Elwyn et al.   BMJ Evidence-Based Medicine

Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection

(2021) Louis Bernard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cementless One-Stage Revision in Chronic Periprosthetic Hip Joint Infection. Ninety-One Percent Infection Free Survival in 56 Patients at Minimum 2-Year Follow-Up

(2018) Jeppe Lange et al.   JOURNAL OF ARTHROPLASTY

Are We Winning or Losing the Battle With Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and Mortality Risk for the Medicare Population

(2018) Steven M. Kurtz et al.   JOURNAL OF ARTHROPLASTY

The Role of Rifampin against Staphylococcal Biofilm Infections in Vitro, in Animal Models, and in Orthopedic Device-Related Infections.

(2018) Werner Zimmerli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Outcome of short versus long interval in two-stage exchange for periprosthetic joint infection: a prospective cohort study

(2018) Tobias Winkler et al.   ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY

Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

(2014) D. Rodríguez-Pardo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Surgical Skill and Complication Rates after Bariatric Surgery

(2013) John D. Birkmeyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

(2012) D. R. Osmon et al.   CLINICAL INFECTIOUS DISEASES

The “Forgotten Joint” as the Ultimate Goal in Joint Arthroplasty

(2011) Henrik Behrend et al.   JOURNAL OF ARTHROPLASTY